Literature DB >> 23035233

Attenuation of bunyamwera orthobunyavirus replication by targeted mutagenesis of genomic untranslated regions and creation of viable viruses with minimal genome segments.

Béryl Mazel-Sanchez1, Richard M Elliott.   

Abstract

Bunyamwera virus (BUNV) is the prototype virus for both the genus Orthobunyavirus and the family Bunyaviridae. BUNV has a tripartite, negative-sense RNA genome. The coding region of each segment is flanked by untranslated regions (UTRs) that are partially complementary. The UTRs play an important role in the virus life cycle by promoting transcription, replication, and encapsidation of the viral genome. Using reverse genetics, we generated recombinant viruses that contained deletions within the 3' and/or 5' UTRs of the L or M segments to determine the minimal UTRs competent for virus viability. We then generated viruses carrying deleted UTRs in all three segments. These viruses were grossly attenuated in tissue culture, being significantly impaired in their ability to produce plaques in BHK cells, and had a reduced capacity to cause host cell protein shutoff. After serial passage in tissue culture, some viruses partially recovered fitness, generating higher titers and producing larger plaques. We determined the complete nucleotide sequence for each virus. The deleted UTR sequences were maintained, and no amino acid changes were observed in the nonstructural proteins (NSs and NSm), the nucleocapsid protein (N), or the Gn glycoprotein. One virus had a single amino acid substitution in Gc. Three viruses contained amino acid changes in the viral polymerase that mostly occurred in the C-terminal domain of the L protein. Although the role of this domain remains unknown, we suggest that those changes might be involved in the evolution of the polymerase to recognize the deleted UTRs more efficiently.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23035233      PMCID: PMC3503023          DOI: 10.1128/JVI.02253-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  RNA binding properties of bunyamwera virus nucleocapsid protein and selective binding to an element in the 5' terminus of the negative-sense S segment.

Authors:  J C Osborne; R M Elliott
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Interferon antagonist NSs of La Crosse virus triggers a DNA damage response-like degradation of transcribing RNA polymerase II.

Authors:  Paul Verbruggen; Marius Ruf; Gjon Blakqori; Anna K Överby; Martin Heidemann; Dirk Eick; Friedemann Weber
Journal:  J Biol Chem       Date:  2010-11-30       Impact factor: 5.157

3.  Genetic elements regulating packaging of the Bunyamwera orthobunyavirus genome.

Authors:  Alain Kohl; Anice C Lowen; Vincent H J Léonard; Richard M Elliott
Journal:  J Gen Virol       Date:  2006-01       Impact factor: 3.891

4.  Requirement of the N-terminal region of orthobunyavirus nonstructural protein NSm for virus assembly and morphogenesis.

Authors:  Xiaohong Shi; Alain Kohl; Vincent H J Léonard; Ping Li; Angela McLees; Richard M Elliott
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

5.  Rescue of a segmented negative-strand RNA virus entirely from cloned complementary DNAs.

Authors:  A Bridgen; R M Elliott
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

6.  A neurotropic virus isolated from Aedes mosquitoes caught in the Semliki forest.

Authors:  K C SMITHBURN; A J HADDOW; A F MAHAFFY
Journal:  Am J Trop Med Hyg       Date:  1946-03       Impact factor: 2.345

7.  The Bunyamwera virus nonstructural protein NSs inhibits viral RNA synthesis in a minireplicon system.

Authors:  F Weber; E F Dunn; A Bridgen; R M Elliott
Journal:  Virology       Date:  2001-03-01       Impact factor: 3.616

8.  Bunyaviridae RNA polymerases (L-protein) have an N-terminal, influenza-like endonuclease domain, essential for viral cap-dependent transcription.

Authors:  Juan Reguera; Friedemann Weber; Stephen Cusack
Journal:  PLoS Pathog       Date:  2010-09-16       Impact factor: 6.823

9.  The small genome segment of Bunyamwera orthobunyavirus harbours a single transcription-termination signal.

Authors:  Gjon Blakqori; Anice C Lowen; Richard M Elliott
Journal:  J Gen Virol       Date:  2012-04-18       Impact factor: 3.891

10.  Functional analysis of the Bunyamwera orthobunyavirus Gc glycoprotein.

Authors:  Xiaohong Shi; Josthna Goli; Gordon Clark; Kristina Brauburger; Richard M Elliott
Journal:  J Gen Virol       Date:  2009-07-01       Impact factor: 3.891

View more
  16 in total

1.  In memoriam--Richard M. Elliott (1954-2015).

Authors:  Benjamin Brennan; Friedemann Weber; Richard Kormelink; Esther Schnettler; Michèle Bouloy; Anna-Bella Failloux; Scott C Weaver; John K Fazakerley; Rennos Fragkoudis; Mark Harris; John N Barr; Peter Palese; Adolfo García-Sastre; Robert G Dalziel; Bernadette M Dutia; Anice C Lowen; John Steel; Richard E Randall; W Paul Duprex; Charles M Rice; Robert B Tesh; Frederick A Murphy; Hideki Ebihara; Pedro F C Vasconcelos; Marcio R Nunes; Anthony R Fooks; Geoffrey L Smith; Ian Goodfellow; Hanu R Pappu; Robert A Lamb; Reay G Paterson; Stephen Higgs; Dana L Vanlandingham; Ralf G Dietzgen; J Stephen Lodmell; Stuart T Nichol; Janet Daly; Diane E Ullman; Alexander Plyusnin; Angelina Plyusnina; Stacey Efstathiou; Roger Hewson; Noël Tordo; Sara Cherry; Chris Boutell; Margaret J Hosie; Pablo R Murcia; James C Neil; Massimo Palmarini; Arvind H Patel; Brian J Willett; Alain Kohl; John McLauchlan
Journal:  J Gen Virol       Date:  2015-08       Impact factor: 3.891

2.  Mutagenic Analysis of Hazara Nairovirus Nontranslated Regions during Single- and Multistep Growth Identifies both Attenuating and Functionally Critical Sequences for Virus Replication.

Authors:  Daniele F Mega; Jack Fuller; Beatriz Álvarez-Rodríguez; Jamel Mankouri; Roger Hewson; John N Barr
Journal:  J Virol       Date:  2020-08-17       Impact factor: 5.103

3.  Flexibility of bunyavirus genomes: creation of an orthobunyavirus with an ambisense S segment.

Authors:  Ingeborg van Knippenberg; Richard M Elliott
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

4.  Evolution of the Bunyamwera virus polymerase to accommodate deletions within genomic untranslated region sequences.

Authors:  Béryl Mazel-Sanchez; Richard M Elliott
Journal:  J Virol       Date:  2015-01-21       Impact factor: 5.103

5.  Genetic analysis of members of the species Oropouche virus and identification of a novel M segment sequence.

Authors:  Natasha L Tilston-Lunel; Joseph Hughes; Gustavo Olszanski Acrani; Daisy E A da Silva; Raimunda S S Azevedo; Sueli G Rodrigues; Pedro F C Vasconcelos; Marcio R T Nunes; Richard M Elliott
Journal:  J Gen Virol       Date:  2015-03-03       Impact factor: 3.891

6.  Genome sequence analysis of in vitro and in vivo phenotypes of Bunyamwera and Ngari virus isolates from northern Kenya.

Authors:  Collins Odhiambo; Marietjie Venter; Konongoi Limbaso; Robert Swanepoel; Rosemary Sang
Journal:  PLoS One       Date:  2014-08-25       Impact factor: 3.240

7.  Establishment of a reverse genetics system for Schmallenberg virus, a newly emerged orthobunyavirus in Europe.

Authors:  Richard M Elliott; Gjon Blakqori; Ingeborg C van Knippenberg; Elina Koudriakova; Ping Li; Angela McLees; Xiaohong Shi; Agnieszka M Szemiel
Journal:  J Gen Virol       Date:  2012-12-19       Impact factor: 3.891

8.  The consequences of reconfiguring the ambisense S genome segment of Rift Valley fever virus on viral replication in mammalian and mosquito cells and for genome packaging.

Authors:  Benjamin Brennan; Stephen R Welch; Richard M Elliott
Journal:  PLoS Pathog       Date:  2014-02-13       Impact factor: 6.823

9.  Evolutionary reversion of live viral vaccines: Can genetic engineering subdue it?

Authors:  J J Bull
Journal:  Virus Evol       Date:  2015-01-01

Review 10.  Orthobunyaviruses: recent genetic and structural insights.

Authors:  Richard M Elliott
Journal:  Nat Rev Microbiol       Date:  2014-09-08       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.